889120-62-1

Basic information

• Product Name: Carbamic acid, [3-[2-[[[2-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]amino]carbonyl]- 5-(1,1-dimethylethyl)phenoxy]-2,2-dimethylpropyl]-, 1,1-dimethylethyl ester
• CAS NO: 889120-62-1
• Molecular Formula: C33H41ClN4O5
• Molecular Weight: 609.165
• Mol File: 889120-62-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [3-[2-[[[2-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]amino]carbonyl]- 5-(1,1-dimethylethyl)phenoxy]-2,2-dimethylpropyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [3-[2-[[[2-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]amino]carbonyl]- 5-(1,1-dimethylethyl)phenoxy]-2,2-dimethylpropyl]-, 1,1-dimethylethyl ester(889120-62-1)
• EPA Substance Registry System: Carbamic acid, [3-[2-[[[2-[[(5-chloro-2-pyridinyl)amino]carbonyl]phenyl]amino]carbonyl]- 5-(1,1-dimethylethyl)phenoxy]-2,2-dimethylpropyl]-, 1,1-dimethylethyl ester(889120-62-1)

Safety Data

• Hazardous Substances Data: 889120-62-1(Hazardous Substances Data)

Upstream product

• 21003-83-8 methyl 4-tert-butyl-2-hydroxybenzoate 
• 184357-44-6 tert-butyl (3-hydroxy-2,2-dimethylpropyl)carbamate 
• 610-14-0 2-nitrobenzyl chloride 
• 161398-79-4 3-tert-butyl-1-(methoxymethoxy)benzene 
• 585-34-2 3-tert-butylphenyol 
• 280771-60-0 N-(5-chloropyridine-2-yl)-2-nitrobenzamide 
• 889108-00-3 2-(3-tert-butoxycarbonylamino-2,2-dimethylpropoxy)-4-(tert-butyl)-benzoic acid 
• 889125-79-5 methyl 2-(3-tert-butoxycarbonylamino-2,2-dimethylpropoxy)-4-(tert-butyl)-benzoate 
• 852370-27-5 4-tert-butyl-2-(methoxymethoxy)benzoic acid 
• 1072-98-6 5-chloro-2-pyridylamine 
• 280771-61-1 N-(5-chloro-2-pyridinyl)(2-amino)phenylcarboxamide 

Downstream Products

• 889120-63-2 2-[2-(3-amino-2,2-dimethylpropoxy)-4-(tert-butyl)benzoylamino]-N-(5-chloropyridin-2-yl)benzamide 

Relevant articles and documents

Anthranilamide inhibitors of factor Xa

SAR about the B-ring of a series of N2-aroyl anthranilamide factor Xa (fXa) inhibitors is described. B-ring o-aminoalkylether and B-ring p-amine probes of the S1′ and S4 sites, respectively, afforded picomolar fXa inhibitors that performed well in in vitro anticoagulation assays.